U.S. China Tech Trade Restrictions Lifted in 2025
The U.S. government has lifted trade restrictions on Arrow Electronics' Chinese affiliates, restoring a critical link in the global electronics supply chain. This move signals a potential easing of trade tensions and benefits U.S. companies reliant on Chinese manufacturing and distribution.
Your Basket's Financial Footprint
Market capitalisation breakdown for the basket focused on companies sensitive to US-China tech trade policy changes.
- Large-cap dominance generally implies lower volatility, more stability, and closer tracking to broad market moves.
- Treat this basket as a core holding for diversification, not a speculative growth trade.
- Tends to deliver steady long-term value rather than likely rapid, short-term gains.
ARW: $6.14B
TSM: $1.23T
ASML: $397.24B
- Other
About This Group of Stocks
Our Expert Thinking
The U.S. government's decision to lift trade restrictions on major electronics distributors signals a potential shift towards a more nuanced approach to China trade policy. This creates opportunities for companies deeply integrated with Chinese manufacturing and distribution networks to benefit from reduced regulatory friction and more stable operations.
What You Need to Know
This group focuses on electronics component distributors, semiconductor manufacturers, and technology hardware companies whose business models rely heavily on Chinese supply chains. These firms are particularly sensitive to U.S.-China trade policy changes and could see improved financial performance as regulatory uncertainty decreases.
Why These Stocks
These companies were handpicked by professional analysts based on their significant exposure to Chinese manufacturing and distribution networks. They represent tactical investment opportunities positioned to benefit from easing trade tensions and the restoration of critical global supply chain links.
Why You'll Want to Watch These Stocks
Trade Barriers Lifting
The U.S. government's decision to ease restrictions creates immediate opportunities for companies with Chinese supply chain dependencies. This policy shift could unlock previously constrained business operations and revenue streams.
Supply Chain Recovery
Electronics distributors and semiconductor companies are experiencing renewed stability as regulatory uncertainty decreases. This restoration of critical global supply links could drive significant operational improvements and cost savings.
Policy-Sensitive Gains
These stocks are uniquely positioned to benefit from evolving U.S.-China trade relations. As tensions ease and business normalises, companies with deep Chinese integration could see substantial performance improvements ahead of broader market recognition.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Railroad Investment: Beyond the $85 Billion Merger
Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.
Oracle TikTok Deal May Boost Stocks in 2025
TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.